Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 839-842, April 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, S. E.
Right arrow Articles by Salsbury, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, S. E.
Right arrow Articles by Salsbury, A. J.

Effect of (±)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane on Tumor Blood Vessels and Its Relationship to the Antimetastatic Effect in the Lewis Lung Carcinoma

Sandra E. James and Alan J. Salsbury

Cancer Chemotherapy Department, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, WC2A 3PX [S. E. J.], and Haematology Department, Brompton Hospital, Fulham Road, London, S.W. 3 [A. J. S.], England

(±)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane in C57/BL female mice bearing the Lewis lung carcinoma inhibits metastases at doses that do not influence the growth of the primary implant. Variation of dose level and time of administration of the drug indicated that its antimitotic action did not contribute directly to its antimetastatic effect. Dose levels that gave highly significant inhibition of metastases produced profound vascular changes in the primary tumors. In the control and ineffectively treated tumors, the vessels were poorly formed sinusoidal channels lined with malignant cells, and frequent areas of hemorrhage were present. In contrast, tumors of treated mice with no evidence of metastatic growth had discreet, well-endothelialized blood vessels, and no hemorrhages were observed. These observations are compatible with the explanation that the antimetastatic effect is due to changes in the vasculature that prevent the entry of Lewis lung carcinoma cells into the circulation and hence their release from the primary tumor.

Received 9/10/73. Accepted 1/ 8/74.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. M. Rybak, E. Sanovich, M. G. Hollingshead, S. D. Borgel, D. L. Newton, G. Melillo, D. Kong, G. Kaur, and E. A. Sausville
"Vasocrine" Formation of Tumor Cell-lined Vascular Spaces: Implications for Rational Design of Antiangiogenic Therapies
Cancer Res., June 1, 2003; 63(11): 2812 - 2819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.